Representativeness of participants in a randomized controlled trial on modalities of monitoring oral HIV pre-exposure prophylaxis use
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
We assessed whether participants in the EZI-PrEP study, a non-inferiority trial evaluating online and six-monthly monitoring of oral HIV pre-exposure prophylaxis (PrEP), represent the broader population of PrEP users in the Netherlands.
Methods
We conducted a cross-sectional study using routinely collected data from September 2021 to August 2022 at four sexual health centres (SHCs) in the Netherlands. Socio-demographic characteristics, sexual behaviour, and prevalence of bacterial STIs were compared between EZI-PrEP participants at baseline and other PrEP users during their first PrEP monitoring visit in said time period.
Results
The analysis included 469 EZI-PrEP participants and 5196 other PrEP users; respectively 99% and 96% were men who have sex with men (MSM). EZI-PrEP participants were less often transgender or gender divers persons (TGDP) (1% vs. 4%, p<0.001), older (median age=36 vs. 34 years, p=0.004), more often born in the Netherlands (68% vs. 58%, p<0.001), and more often completed a university/college degree (81% vs. 76%, p=0.01). They reported more group sex (38% vs. 33%, p=0.023) and condomless anal sex (95% vs. 92%, p=0.004), but less often sex work (1% vs. 6%, p<0.001). Prevalence of bacterial STIs was similar between groups (19% vs 18%, p=0.766).
Conclusions
The similar STI prevalence suggests comparable risk for HIV acquisition among EZI-PrEP participants and other PrEP users, making EZI-PrEP study outcomes applicable to a broader population of PrEP users. However, under-representation of TGDPs, sex workers, individuals not born in the Netherlands, and individuals without university or college degree may limit generalizability.
